Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

217
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
217
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

215
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
215
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

173
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
173
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

206
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
206
Introduction To Health Care Delivery System01:18

Introduction To Health Care Delivery System

3.7K
The healthcare system is constantly changing and complex. Various services are available from different healthcare providers, but gaining access to these services has become challenging for people with limited healthcare insurance. Uninsured people present a challenge to healthcare because they frequently postpone or forego treatment.
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
3.7K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

189
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
189

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial and Ethnic Differences in Mobile App Use for Meeting Sexual Partners Among Young Men Who Have Sex With Men and Young Transgender Women: Cross-Sectional Study.

JMIR public health and surveillance·2024
Same author

Automated Dispensing Cabinet Functionality Expansion to Reduce Controlled Substance Inventory Discrepancies.

Hospital pharmacy·2022
Same author

Burnout Among Health System Pharmacists: Presentation, Consequences, and Recommendations.

Hospital pharmacy·2021
Same author

Drug purchase price volatility in an academic medical center.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2021
Same author

Gender and Minority Considerations in Pharmacy School Student Wellbeing.

American journal of pharmaceutical education·2020
Same author

Health-system pharmacy department preparation and support for nursing workforce disruption.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2020

Related Experiment Video

Updated: Jan 3, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K

Cultural Competence Considerations for Health-System Pharmacists.

Megan Park Corsi1, Joel D Jackson1, Bryan C McCarthy1

  • 1The University of Chicago Medicine, IL, USA.

Hospital Pharmacy
|November 26, 2019
PubMed
Summary

Health system pharmacists can improve patient outcomes by enhancing cultural competence. Utilizing communication tools like the LARA (Listen, Affirm, Respond, and Add) methodology and teach-back method optimizes medication use for diverse populations.

Keywords:
communicationcounselingcultural competencedisparate carehealth system pharmacist

More Related Videos

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.3K

Related Experiment Videos

Last Updated: Jan 3, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
07:23

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications

Published on: October 20, 2023

1.8K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.3K

Area of Science:

  • Pharmacy
  • Health Disparities
  • Cultural Competency

Background:

  • Significant disparities in healthcare utilization and patient outcomes exist across diverse populations in the U.S.
  • Health system pharmacists play a crucial role in addressing these disparities.
  • Optimizing medication use requires culturally sensitive patient care.

Purpose of the Study:

  • To introduce cultural competency concepts to health system pharmacists.
  • To provide communication tools for personalizing care for diverse patients.
  • To highlight key cultural considerations in pharmaceutical practice.

Main Methods:

  • Review of communication strategies for culturally integrated discussions.
  • Discussion of specific tools: LARA (Listen, Affirm, Respond, and Add) methodology, Kleinman's explanatory model, and teach-back method.
  • Identification of cultural considerations relevant to pharmacists.

Main Results:

  • Cultural competence is essential for health system pharmacists to optimize medication use.
  • Communication tools facilitate culturally sensitive patient interactions.
  • Awareness of cultural factors like spiritual care, non-pharmacologic therapy, privacy, and distrust is vital.

Conclusions:

  • Health system pharmacists must recognize the influence of cultural beliefs and traditions on patient care.
  • Increasing pharmacist awareness of cultural nuances can reduce health disparities.
  • Personalized, culturally competent care leads to improved patient outcomes.